FibroBiologics (FBLG) Times Interest Earned (2023 - 2026)
FibroBiologics (FBLG) posted quarterly Times Interest Earned of -$2.62 for Q2 2026, down 81.45% year-over-year from -$14.1 in Q2 2025, and down 29.53% on a QoQ basis from -$2.02 in Q1 2026.
FibroBiologics (FBLG) Times Interest Earned (2023 - 2026) Analysis & Trends
FibroBiologics has reported Times Interest Earned for 4 years, with the latest figure at -$2.62 in Q2 2026.
- Times Interest Earned for Q2 2026 came in at -$2.62, down 81.45% year-over-year; the trailing twelve-month figure through Jun 2026 was -$10.85 (down 110.1% YoY), and the FY2025 annual result was -$1.8, up 30.97% from the prior year.
- Times Interest Earned declined to -$2.62 in Q2 2026, from -$2.02 in the prior quarter.
- Over five years, Times Interest Earned peaked at $14.15 in Q3 2023 and troughed at -$862.5 in Q1 2024.
- A 4-year average of -$170.0 and a median of -$8.12 in 2025 frame the typical range for Times Interest Earned.
- The widest annual swing landed in 2024, when Times Interest Earned plunged 5040.73%; it then surged 99.78% in 2025.
- A 4-year view of Times Interest Earned shows it stood at -$16.99 in 2023, then tumbled by 3542.15% to -$618.67 in 2024, then jumped by 97.9% to -$13.02 in 2025, then jumped by 79.9% to -$2.62 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$2.62 in Q2 2026, -$2.02 in Q1 2026, and -$13.02 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | FibroBiologics | 8.97 Mn | 8.97 Mn | - | -576.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.62 |
| Mar 31, 2026 | -2.02 |
| Dec 31, 2025 | -13.02 |
| Sep 30, 2025 | -1.74 |
| Jun 30, 2025 | -7.80 |
| Mar 31, 2025 | -3.22 |
| Dec 31, 2024 | -618.67 |
| Sep 30, 2024 | -1.11 |
| Jun 30, 2024 | -644.80 |
| Mar 31, 2024 | -862.50 |
| Dec 31, 2023 | -2,480.00 |
| Jun 30, 2023 | -209.30 |
| Mar 31, 2023 | -16.78 |